Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $102.4500 (0.29%) ($101.1340 - $104.0150) on Tue. Oct. 13, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.29% (three month average) | RSI | 74 | Latest Price | $102.4500(0.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.2% a day on average for past five trading days. | Weekly Trend | LGND advances 4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(51%) IWM(49%) IWC(48%) | Factors Impacting LGND price | LGND will decline at least -1.145% in a week (0% probabilities). VIXM(-21%) UUP(-16%) VXX(-14%) IGOV(-7%) UNG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.145% (StdDev 2.29%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $102.94(-0.48%) | 10 Day Moving Average | $100.82(1.62%) | 20 Day Moving Average | $97.44(5.14%) | To recent high | -19.2% | To recent low | 14.4% | Market Cap | $1.646b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |